CSIMarket
 


Oramed Pharmaceuticals Inc   (ORMP)
Other Ticker:  
 

Oramed Pharmaceuticals Inc 's Quick Ratio

ORMP's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




ORMP Quick Ratio (Feb 29 2020)
II. Quarter
(Nov 30 2019)
I. Quarter
(Aug 31 2019)
IV. Quarter
(May 31 2019)
III. Quarter
(Feb 28 2019)
II. Quarter
Y / Y Current Liabilities Change 113.37 % 51.5 % 16.58 % -55.42 % -49.11 %
Y / Y Cash & cash equivalent Change 0.96 % 4.18 % 5.97 % 12.07 % 37.07 %
Quick Ratio MRQ 5.65 6.56 6.08 10.42 11.93
Overall Ranking # # # # #
Seq. Current Liabilities Change 11.49 % -13.43 % 111.22 % 4.66 % -20.84 %
Seq. Cash & cash equivalent Change -4.01 % -6.66 % 23.24 % -8.58 % -0.94 %



Quick Ratio second quarter 2020 Comment
Due to increase in Current Liabilities in the second quarter 2020, Quick Ratio fell to 5.65 below Oramed Pharmaceuticals Inc average.

Within Major Pharmaceutical Preparations industry Oramed Pharmaceuticals Inc achieved highest Quick Ratio than Oramed Pharmaceuticals Inc in second quarter 2020. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are ORMP Segments?
See Quick Ratio ORMP on the trailing twelve month basis
Quick Ratio second quarter 2020 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 1
Healthcare Sector # 2
Overall Market # 6


Quick Ratio Statistics
High Average Low
66.8 13.83 3.7
(Feb 28 2014)   (Nov 30 2017)




Financial Statements
Oramed Pharmaceuticals Inc 's Current Liabilities $ 5 Millions Visit ORMP's Balance sheet
Oramed Pharmaceuticals Inc 's Cash & cash equivalent $ 29 Millions Visit ORMP's Balance sheet
Source of ORMP's Sales Visit ORMP's Sales by Geography




Companies with similar Quick Ratio in the quarter endingFeb 29 2020, within Major Pharmaceutical Preparations Industry Quick RatioFeb 29 2020 MRQ Cash & cash equivalentFeb 29 2020 MRQ Current Liabilities
Kura Oncology Inc   14.91 $ 216.935  Millions$ 14.554  Millions
Cymabay Therapeutics Inc   14.78 $ 176.232  Millions$ 11.922  Millions
Diamedica Therapeutics Inc   14.61 $ 12.843  Millions$ 0.879  Millions
Glycomimetics Inc  14.59 $ 154.875  Millions$ 10.612  Millions
Intra cellular Therapies Inc   14.45 $ 448.954  Millions$ 31.076  Millions
Ideaya Biosciences Inc   14.24 $ 87.863  Millions$ 6.170  Millions
Trevena Inc  14.22 $ 28.090  Millions$ 1.975  Millions
Cytokinetics Inc  14.05 $ 220.706  Millions$ 15.711  Millions
Bridgebio Pharma Inc   13.94 $ 905.175  Millions$ 64.914  Millions
Seres Therapeutics Inc   13.60 $ 75.094  Millions$ 5.521  Millions
Savara Inc   13.58 $ 104.987  Millions$ 7.729  Millions
Apellis Pharmaceuticals inc   13.47 $ 646.694  Millions$ 48.008  Millions
Rocket Pharmaceuticals Inc   13.07 $ 275.895  Millions$ 21.114  Millions
Marker Therapeutics Inc   12.74 $ 40.300  Millions$ 3.164  Millions
Adial Pharmaceuticals Inc   12.70 $ 4.952  Millions$ 0.390  Millions
Mirati Therapeutics Inc   12.54 $ 695.360  Millions$ 55.450  Millions
Sage Therapeutics Inc   12.40 $ 872.757  Millions$ 70.360  Millions
Kala Pharmaceuticals Inc   12.36 $ 196.456  Millions$ 15.898  Millions
Aravive Inc   12.24 $ 60.700  Millions$ 4.959  Millions
Catabasis Pharmaceuticals Inc  12.01 $ 55.103  Millions$ 4.590  Millions
Vanda Pharmaceuticals Inc   11.99 $ 312.326  Millions$ 26.045  Millions
Mirum Pharmaceuticals Inc   11.78 $ 159.531  Millions$ 13.548  Millions
Akcea Therapeutics Inc   11.60 $ 421.302  Millions$ 36.332  Millions
Ngm Biopharmaceuticals Inc  11.54 $ 328.469  Millions$ 28.462  Millions
Tonix Pharmaceuticals Holding Corp   11.53 $ 30.672  Millions$ 2.660  Millions
Guardion Health Sciences Inc   11.22 $ 12.890  Millions$ 1.148  Millions
Provention Bio Inc   11.10 $ 76.629  Millions$ 6.903  Millions
Pfenex Inc   10.95 $ 65.602  Millions$ 5.991  Millions
Phasebio Pharmaceuticals Inc  10.61 $ 59.441  Millions$ 5.604  Millions
Crinetics Pharmaceuticals Inc   10.48 $ 112.802  Millions$ 10.760  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

PHLD's Profile

Stock Price

PHLD's Financials

Business Description

Fundamentals

Charts & Quotes

PHLD's News

Suppliers

PHLD's Competitors

Customers & Markets

Economic Indicators

PHLD's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071